Abstract:
Maleate salts of (6-(5-chloro-2-pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazine) are provided. The salts are useful to provide blood levels of eszopiclone that are independent of fasting state.
Abstract:
The invention relates to a pacifier and nipple member for delivery of active ingredients into the oral cavity of an infant or patient. The pacifier includes a porous nipple member and a base member adapted to remain outside the oral cavity of the infant. The porous nipple member includes at least one reservoir or chamber therein for receiving a thin-film containing an active ingredient. The base member may be removably attached to the neck of the nipple member, or the nipple and base members may form a single unit. Reusable and disposable forms are disclosed.
Abstract:
Pharmaceutical compositions of L malate salts of (6-(5-chloro-2-pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazine) are provided.
Abstract:
A novel L-malate salt of (6-(5-chloro-2-pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazine) is provided.
Abstract:
The invention relates to a pacifier and nipple member for delivery of active ingredients into the oral cavity of an infant or patient. The pacifier includes a porous nipple member and a base member adapted to remain outside the oral cavity of the infant. The porous nipple member includes at least one reservoir or chamber therein for receiving a thin-film containing an active ingredient. The base member may be removably attached to the neck of the nipple member, or the nipple and base members may form a single unit. Reusable and disposable forms are disclosed.
Abstract:
L-malate salts of (6-(5-chloro-2-pyridyl)-5-[(4-methyl-1-piperazinyl) carbonyloxy]-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazine) are provided.
Abstract:
A novel maleate salt of (6-(5-chloro-2-pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazine) is provided.
Abstract:
Pharmaceutical compositions of maleate salts of (6-(5-chloro-2-pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7-dihydro-5H-pyrrolo [3,4-b]pyrazine) are provided. The maleate salts are sleep agents useful in oral dosage forms.